Angela Williams

The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey

Mike Thomas, Stephen Kay, James Pike et al. · Primary Care Respiratory Journal · 2009 · 295 citations · Full text

Pharmacy, Internal Medicine, Health Assessment +10

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control

Mike Thomas, David Price, Henry Chrystyn et al. · BMC Pulmonary Medicine · 2009 · 146 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

Karine Briot, Anthony A. Portale, Maria Luisa Brandi et al. · RMD Open · 2021 · 72 citations · Full text

Medicine, Pharmacotherapy, Pain Management +16

Defining COPD exacerbations: impact on estimation of incidence and burden in primary care

John O’Reilly, Angela Williams, Kay Holt · Primary Care Respiratory Journal · 2006 · 71 citations · Full text

Medicine, Health Sciences, Epidemiology +13

Health status impairment and costs associated with COPD exacerbation managed in hospital

John O’Reilly, Angela Williams, Leanne Rice · International Journal of Clinical Practice · 2007 · 64 citations

Pharmacy, Pharmacoeconomics, Cost-utility Analysis +16